L. Tho
Oncology · 2010–2019
A researcher in the Science corpus: 2 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Oncology — 46 citations into it
- Molecular Biology — 43 citations into it
Whom L. Tho trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from L. Tho's perspective
Ordered by how strongly the researchers L. Tho trusts endorse each paper. Same corpus, a different order for every researcher.
- Sensing DNA Damage Through ATRIP Recognition of RPA-ssDNA Complexes (Science)
- DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation (Nature)
- ATR disruption leads to chromosomal fragmentation and early embryonic lethality. (Genes & Development)
- Cell cycle checkpoint signaling through the ATM and ATR kinases. (Genes & Development)
- Cell-cycle checkpoints and cancer (Nature)
- ATR: An Essential Regulator of Genome Integrity (Nature reviews. Molecular cell biology)
- Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro. (Proceedings of the National Academy of Sciences of the United States of America)
- Chk1 and Chk2 kinases in checkpoint control and cancer. (Cancer Cell)
- When mutants gain new powers: news from the mutant p53 field (Nature Reviews. Cancer)
- Homologous recombination in DNA repair and DNA damage tolerance (Cell Research)
Their papers
- The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer. (2010) — 1,239 citations
- Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial. (2019) — 2,778 citations